Home > Insider Trading > Diamedica Therapeutics Inc.

Diamedica Therapeutics Inc. (DMAC)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

1 - 10
Next >>

DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q4 2024 Earnings Call Transcript

Operator: Good morning, ladies and gentlemen, and welcome to the DiaMedica Therapeutics Full Year 2024 Conference Call.

Keep Reading →

March 19th, 2025 - News Transcripts

DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q3 2024 Earnings Call Transcript

Operator: Good morning ladies and gentlemen and welcome to the DiaMedica Therapeutics Third Quarter 2024 Conference Call.

Keep Reading →

November 15th, 2024 - News Transcripts

DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q2 2024 Earnings Call Transcript

Operator: Good morning ladies and gentlemen and welcome to the DiaMedica Therapeutics Second Quarter 2024 Conference Call.

Keep Reading →

August 12th, 2024 - News Transcripts

DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q1 2024 Earnings Call Transcript

Operator: Good morning, ladies and gentlemen, and welcome to the DiaMedica Therapeutics First Quarter 2024 Conference Call.

Keep Reading →

May 13th, 2024 - News Transcripts

DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q4 2023 Earnings Call Transcript

Operator: Good morning, ladies and gentlemen, and welcome to the DiaMedica Therapeutics Full Year 2023 Conference Call.

Keep Reading →

March 25th, 2024 - News Transcripts

Billionaire Lee Cooperman's 10 Stock Picks with Huge Upside Potential

In this article, we discuss billionaire Lee Cooperman's 10 stock picks with huge upside potential. To skip the details of Mr.

Keep Reading →

December 4th, 2023 - Hedge Funds News

DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q3 2023 Earnings Call Transcript

Operator: Good morning, ladies and gentlemen, and welcome to the DiaMedica Therapeutics Third Quarter 2023 Conference Call.

Keep Reading →

November 15th, 2023 - News Transcripts

DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q2 2023 Earnings Call Transcript

Operator: Good morning, ladies and gentlemen, and welcome to the DiaMedica Therapeutics Second Quarter 2023 Conference Call.

Keep Reading →

August 17th, 2023 - News Transcripts

Hedge Fund and Insider Trading News: Crispin Odey, Starboard Value, Tiger Management, DiaMedica Therapeutics Inc (DMAC), Asana, Inc. (ASAN), and More

Crispin Odey, on paper, is a billionaire — commanding a vast wealth built over decades that’s unlikely to unravel as fast as his tenure atop Odey Asset Management.

Keep Reading →

June 30th, 2023 - Hedge Funds Insider Trading

DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q1 2023 Earnings Call Transcript

Operator: Good morning, ladies and gentlemen, and welcome to the DiaMedica Therapeutics First Quarter 2023 Conference Call.

Keep Reading →

May 17th, 2023 - News Transcripts

1 - 10
Next >>

Follow Insider Monkey at Twitter

Insider Monkey Quarterly Strategy

+373.4% Insider Monkey Quarterly Strategy

+154.9% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF

300%

200%

100%

Subscribe Now

Returns since its inception in May 2014 (through February 19th, 2025)

Hedge Fund Resource Center

How to Best Use Insider Monkey to Increase Your Returns
Why Track Hedge Funds?
Download a Free Edition!
Why You Should DUMP Your Hedge Funds
6 Things You Didn't Know About Hedge Funds

Billionaire Hedge Funds

Warren Buffett

Berkshire Hathaway

$293,447,417,000

David Einhorn

Greenlight Capital

$1,491,303,000

George Soros

Soros Fund Management

$5,416,602,000

Jim Simons

Renaissance Technologies

$77,426,184,000

Leon Cooperman

Omega Advisors

$1,886,381,000

Carl Icahn

Icahn Capital LP

$22,521,664,000

Steve Cohen

Point72 Asset Management

$22,767,998,000

John Paulson

Paulson & Co

$3,510,256,000

David Tepper

Appaloosa Management LP

$4,198,712,000

Paul Tudor Jones

Tudor Investment Corp

$6,160,740,000